Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.9 USD | +2.52% | +4.19% | +0.51% |
May. 16 | Scotiabank Adjusts Price Target on Healthpeak Properties to $23 From $22 | MT |
May. 16 | JPMorgan Adjusts Price Target on Healthpeak Properties to $21 From $19, Keeps Neutral Rating | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The opinion of analysts covering the stock has improved over the past four months.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- One of the major weak points of the company is its financial situation.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 58.46 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialized REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.51% | 14.01B | A | ||
+14.97% | 61.99B | A- | ||
+0.84% | 20.31B | A- | ||
+5.45% | 7.99B | B | ||
-5.80% | 6.14B | B- | ||
+14.32% | 3.63B | C- | ||
+2.24% | 3.38B | C+ | ||
+9.16% | 3.22B | C | ||
-6.13% | 3.08B | B+ | ||
+18.32% | 2.87B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DOC Stock
- Ratings Healthpeak Properties, Inc.